Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AI Health Outcomes is a private healthcare technology company focused on artificial intelligence-enabled software tools for patient engagement, education, and clinical research support. The company is best known for CannaBot, an AI chatbot used in the medical cannabis and CBD setting, as well as DrBot and an AI patient recruitment tool for clinical research enrollment. Its offerings appear to be commercial software products rather than a therapeutic drug pipeline, with activity centered on patient-reported outcomes, digital support, and observational research collaborations. The company has been associated with healthcare and clinical research organizations in Pennsylvania and has operated as a small private business based in Chester Springs, Pennsylvania.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AI Health Outcomes.